These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15127878

  • 21. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T, Edelstein CL, Chapman AB, Johnson AM, Tison L, Gill EA, Brosnahan GM, Schrier RW.
    Nephrol Dial Transplant; 1999 May; 14(5):1113-6. PubMed ID: 10344347
    [Abstract] [Full Text] [Related]

  • 22. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
    Barendregt JN, Florijn KW, Muizert Y, Chang PC.
    Nephrol Dial Transplant; 1995 May; 10(8):1332-41. PubMed ID: 8538923
    [Abstract] [Full Text] [Related]

  • 23. Pathogenesis of hypertension in autosomal dominant polycystic kidney disease.
    Chapman AB, Schrier RW.
    Semin Nephrol; 1991 Nov; 11(6):653-60. PubMed ID: 1767138
    [Abstract] [Full Text] [Related]

  • 24. Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease.
    Martinez-Vea A, Gutierrez C, Bardají A, Pastor R, García C, Peralta C, Richart C, Oliver JA.
    Scand J Urol Nephrol; 1998 Sep; 32(5):356-9. PubMed ID: 9825400
    [Abstract] [Full Text] [Related]

  • 25. Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease.
    Seeman T, Dusek J, Vondrák K, Bláhová K, Simková E, Kreisinger J, Dvorák P, Kyncl M, Hríbal Z, Janda J.
    Physiol Res; 2004 Sep; 53(6):629-34. PubMed ID: 15588131
    [Abstract] [Full Text] [Related]

  • 26. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
    Peco-Antić A, Nastić-Mirić D, Babić D, Kostić M.
    Srp Arh Celok Lek; 1999 Sep; 127(9-10):305-11. PubMed ID: 10649899
    [Abstract] [Full Text] [Related]

  • 27. Renin-Angiotensin-aldosterone system in autosomal dominant polycystic kidney disease.
    Tkachenko O, Helal I, Shchekochikhin D, Schrier RW.
    Curr Hypertens Rev; 2013 Feb; 9(1):12-20. PubMed ID: 23971639
    [Abstract] [Full Text] [Related]

  • 28. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents.
    van Hooft IM, Grobbee DE, Derkx FH, de Leeuw PW, Schalekamp MA, Hofman A.
    N Engl J Med; 1991 May 09; 324(19):1305-11. PubMed ID: 2017226
    [Abstract] [Full Text] [Related]

  • 29. Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.
    Lai S, Petramala L, Mastroluca D, Petraglia E, Di Gaeta A, Indino E, Panebianco V, Ciccariello M, Shahabadi HH, Galani A, Letizia C, D'Angelo AR.
    Medicine (Baltimore); 2016 Jul 09; 95(29):e4175. PubMed ID: 27442639
    [Abstract] [Full Text] [Related]

  • 30. The pathogenesis of hypertension in autosomal dominant polycystic kidney disease.
    Wang D, Strandgaard S.
    J Hypertens; 1997 Sep 09; 15(9):925-33. PubMed ID: 9321739
    [Abstract] [Full Text] [Related]

  • 31. Hypertension in autosomal dominant polycystic kidney disease.
    Chapman AB, Stepniakowski K, Rahbari-Oskoui F.
    Adv Chronic Kidney Dis; 2010 Mar 09; 17(2):153-63. PubMed ID: 20219618
    [Abstract] [Full Text] [Related]

  • 32. Hypertension of polycystic kidney disease: mechanisms and hemodynamic alterations.
    Valvo E, Gammaro L, Tessitore N, Panzetta G, Lupo A, Loschiavo C, Oldrizzi L, Fabris A, Rugiu C, Ortalda V.
    Am J Nephrol; 1985 Mar 09; 5(3):176-81. PubMed ID: 3893129
    [Abstract] [Full Text] [Related]

  • 33. Blood pressure and intracranial aneurysms in autosomal dominant polycystic kidney disease.
    Niemczyk M, Pilecki T, Gradzik M, Bujko M, Niemczyk S, Pączek L.
    Kidney Blood Press Res; 2014 Mar 09; 39(6):630-5. PubMed ID: 25571876
    [Abstract] [Full Text] [Related]

  • 34. Renal haemodynamics are not related to genotypes in offspring of parents with essential hypertension.
    Skov K, Madsen JK, Hansen HE, Zagato L, Frandsen E, Bianchi G, Mulvany MJ.
    J Renin Angiotensin Aldosterone Syst; 2006 Mar 09; 7(1):47-55. PubMed ID: 17083073
    [Abstract] [Full Text] [Related]

  • 35. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE, Wilson DM, Burnett JC, Johnson CM, Offord KP.
    Mayo Clin Proc; 1991 Oct 09; 66(10):1010-7. PubMed ID: 1921483
    [Abstract] [Full Text] [Related]

  • 36. Hypertension in autosomal dominant polycystic kidney disease.
    Chapman AB, Gabow PA.
    Kidney Int Suppl; 1997 Oct 09; 61():S71-3. PubMed ID: 9328971
    [No Abstract] [Full Text] [Related]

  • 37. Hypertension in autosomal dominant polycystic kidney disease.
    Bell PE, Hossack KF, Gabow PA, Durr JA, Johnson AM, Schrier RW.
    Kidney Int; 1988 Nov 09; 34(5):683-90. PubMed ID: 2974094
    [Abstract] [Full Text] [Related]

  • 38. Renal vascular resistance in essential hypertension: duplex-Doppler ultrasonographic evaluation.
    Galesić K, Brkljacić B, Sabljar-Matovinović M, Morović-Vergles J, Cvitković-Kuzmić A, Bozikov V.
    Angiology; 2000 Aug 09; 51(8):667-75. PubMed ID: 10959519
    [Abstract] [Full Text] [Related]

  • 39. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J, Henik RA, Brownfield M, Armstrong J.
    Am J Vet Res; 1997 May 09; 58(5):535-40. PubMed ID: 9140564
    [Abstract] [Full Text] [Related]

  • 40. [A circadian profile of arterial pressure in hypertensive patients with diabetes mellitus: relation with affected renal circulation].
    Karpov RS, Koshel'skaia OA.
    Ter Arkh; 2007 May 09; 79(12):12-8. PubMed ID: 18220024
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.